Company Filing History:
3 out of 9 
1 out of 3 
1 out of 2 Years Active: 2018-2022
Title: Innovations by Inventor Per Marin in Diabetes Treatment
Introduction
Per Marin, an innovative inventor based in Vastra Frolunda, Sweden, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and metabolic syndrome. With a total of five patents to his name, Marin's work focuses on developing methods and compositions that address critical health conditions through advanced pharmaceutical compositions.
Latest Patents
Among his latest patents are groundbreaking methods and compositions for treating diabetes and metabolic syndrome. These patents include pharmaceutical compositions that comprise the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates. Notably, these compositions are designed to be substantially free of the 2R,4S ketoconazole enantiomer. Their primary utility lies in reducing cortisol synthesis while effectively treating numerous conditions, including type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, and hypertension. They also offer therapeutic benefits for Metabolic Syndrome and other serious diseases, such as Cushing's Syndrome, depression, and glaucoma.
Career Highlights
Throughout his career, Per Marin has built a strong reputation as a leading figure in pharmaceutical innovation. The collaborations and projects he has participated in reflect a commitment to advancing medical treatments that significantly enhance patient care. His expertise and dedication have been demonstrated through his successful patent applications and the continued evolution of his research.
Collaborations
Per Marin has been associated with prominent companies in the pharmaceutical sector, including Strongbridge Dublin Limited and Cortendo AB (publ). These affiliations have provided him with a platform to collaborate with other experts and further his research in developing effective treatments for metabolic conditions, leveraging the strengths of each organization to push the boundaries of medical innovation.
Conclusion
In conclusion, Per Marin's contributions to pharmaceutical innovations have the potential to transform the treatment landscape for diabetes and metabolic syndrome. His ongoing research and patented inventions underscore the vital role of inventors in creating solutions to modern health challenges, making him a noteworthy figure in the field of pharmaceuticals. As his work continues to evolve, it promises to impact countless lives positively.